|
Tatva Chintan Pharma Chem Ltd.
|
Balance Sheet
|
|
|
You can view the
Balance Sheet
for the last 5 years.
|
Market Cap. (Rs.)
|
1780.14 Cr.
|
P/BV
|
2.41
|
Book Value (Rs.)
|
315.32
|
|
52 Week High/Low (Rs.)
|
1222/621
|
FV/ML
|
10/1
|
P/E(X)
|
311.63
|
|
Bookclosure
|
20/09/2024
|
EPS (Rs.)
|
2.44
|
Div Yield (%)
|
0.13
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| No. of Equity Shares (in Lacs) | 233.92 | 233.92 | 221.65 | 221.65 | 200.88 |
| | | | | | |
| EQUITIES AND LIABILITIES | | | | | |
| SHAREHOLDER'S FUNDS | | | | | |
| Equity Share Capital | 23.39 | 23.39 | 22.17 | 22.17 | 20.09 |
| Total Share Capital | 23.39 | 23.39 | 22.17 | 22.17 | 20.09 |
| | | | | | |
| Reserves and Surplus | 715.43 | 713.69 | 492.63 | 450.92 | 145.88 |
| Total Reserves and Surplus | 715.43 | 713.69 | 492.63 | 450.92 | 145.88 |
| Total Shareholders Funds | 738.82 | 737.08 | 514.79 | 473.09 | 165.96 |
| | | | | | |
| NON-CURRENT LIABILITIES | | | | | |
| Long Term Borrowings | 0.00 | 0.64 | 4.23 | 13.11 | 26.76 |
| Deferred Tax Liabilities [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 2.08 |
| Other Long Term Liabilities | 0.00 | 0.00 | 0.00 | 0.02 | 1.43 |
| Long Term Provisions | 1.40 | 1.33 | 1.15 | 0.65 | 0.55 |
| Total Non-Current Liabilities | 1.40 | 1.97 | 5.38 | 13.78 | 30.82 |
| | | | | | |
| CURRENT LIABILITIES | | | | | |
| Short Term Borrowings | 36.39 | 13.63 | 166.03 | 106.83 | 49.29 |
| Trade Payables | 32.69 | 45.03 | 32.19 | 44.51 | 47.48 |
| Other Current Liabilities | 26.53 | 20.64 | 37.59 | 19.91 | 21.14 |
| Short Term Provisions | 0.42 | 0.36 | 0.33 | 0.18 | 0.11 |
| Total Current Liabilities | 96.03 | 79.66 | 236.13 | 171.43 | 118.02 |
| | | | | | |
| Total Capital And Liabilities | 836.25 | 818.72 | 756.30 | 658.30 | 314.80 |
| | | | | | |
| ASSETS | | | | | |
| NON-CURRENT ASSETS | | | | | |
| Tangible Assets | 528.33 | 426.54 | 195.77 | 159.30 | 120.35 |
| Intangible Assets | 3.12 | 0.35 | 0.48 | 0.32 | 0.10 |
| Capital Work-In-Progress | 21.54 | 72.93 | 230.74 | 51.49 | 9.81 |
| Intangible Assets Under Development | 0.00 | 3.61 | 0.00 | 0.00 | 0.00 |
| Fixed Assets | 552.99 | 503.42 | 426.99 | 211.10 | 130.26 |
| Deferred Tax Assets [Net] | 12.62 | 12.30 | 12.36 | 8.71 | 0.00 |
| Other Non-Current Assets | 5.39 | 5.09 | 3.40 | 2.60 | 0.30 |
| Total Non-Current Assets | 571.00 | 520.81 | 442.75 | 222.42 | 130.55 |
| | | | | | |
| | | | | | |
| CURRENT ASSETS | | | | | |
| Current Investments | 0.00 | 10.05 | 0.00 | 0.00 | 0.00 |
| Inventories | 133.95 | 152.77 | 162.50 | 169.96 | 72.02 |
| Trade Receivables | 82.53 | 69.85 | 84.40 | 56.60 | 90.74 |
| Cash And Cash Equivalents | 14.10 | 38.29 | 44.76 | 176.99 | 5.34 |
| Short Term Loans And Advances | 0.24 | 0.24 | 0.17 | 0.16 | 1.90 |
| OtherCurrentAssets | 34.43 | 26.70 | 21.72 | 32.18 | 14.24 |
| Total Current Assets | 265.25 | 297.91 | 313.56 | 435.89 | 184.25 |
| | | | | | |
| Total Assets | 836.25 | 818.72 | 756.30 | 658.30 | 314.80 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| CONTINGENT LIABILITIES, COMMITMENTS | | | | | |
| Contingent Liabilities | 0.00 | 29.95 | 19.19 | 80.05 | 4.14 |
| | | | | | |
| BONUS DETAILS | | | | | |
| Bonus Equity Share Capital | 0.00 | 12.05 | 12.05 | 12.05 | 12.05 |
